Quest Diagnostics Company Insiders
| DGX Stock | USD 166.45 0.46 0.28% |
Quest Diagnostics employs about 55 K people. The company is managed by 30 executives with a total tenure of roughly 193 years, averaging almost 6.0 years of service per executive, having 1833.33 employees per reported executive. Break down of Quest Diagnostics' management performance can provide insight into the company performance.
| Stephen Rusckowski CEO CEO and President Director and Member of Executive Committee |
| Daniel Stanzione Chairman Non-Executive Chairman of the Board |
Quest Diagnostics' latest congressional trading
Congressional trading in companies like Quest Diagnostics, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Quest Diagnostics by those in governmental positions are based on the same information available to the general public.
| 2025-04-11 | Representative Carol Devine Miller | Acquired Under $15K | Verify | ||
| 2024-02-13 | Senator Tommy Tuberville | Acquired $15K to $50K | Verify | ||
| 2024-01-02 | Senator Thomas R Carper | Acquired Under $15K | Verify |
Quest Diagnostics Management Team Effectiveness
The company has Return on Asset of 0.0613 % which means that on every $100 spent on assets, it made $0.0613 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1395 %, implying that it generated $0.1395 on every 100 dollars invested. Quest Diagnostics' management efficiency ratios could be used to measure how well Quest Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities.Quest Diagnostics Workforce Comparison
Quest Diagnostics Incorporated is rated # 5 in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 422,880. Quest Diagnostics retains roughly 55,000 in number of employees claiming about 13% of equities under Health Care industry.
The company has Net Profit Margin of 0.09 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.14 %, which entails that for every 100 dollars of revenue, it generated $0.14 of operating income. Quest Diagnostics Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Quest Diagnostics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Quest Diagnostics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Quest Diagnostics insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Delaney Mark E over three months ago Acquisition by Delaney Mark E of tradable shares of Quest Diagnostics at 158.025 subject to Rule 16b-3 | ||
Michael Prevoznik over six months ago Disposition of 35146 shares by Michael Prevoznik of Quest Diagnostics at 86.63 subject to Rule 16b-3 | ||
Karthik Kuppusamy over six months ago Disposition of 1775 shares by Karthik Kuppusamy of Quest Diagnostics at 156.9156 subject to Rule 16b-3 | ||
Michael Deppe over six months ago Disposition of tradable shares by Michael Deppe of Quest Diagnostics at 125.02 subject to Rule 16b-3 | ||
Sam Samad over a year ago Disposition of 656 shares by Sam Samad of Quest Diagnostics at 126.36 subject to Rule 16b-3 | ||
John Ziegler over a year ago Sale by John Ziegler of 1953 shares of Quest Diagnostics |
Quest Diagnostics Notable Stakeholders
A Quest Diagnostics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Quest Diagnostics often face trade-offs trying to please all of them. Quest Diagnostics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Quest Diagnostics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Stephen Rusckowski | CEO and President Director and Member of Executive Committee | Profile | |
| Daniel Stanzione | Non-Executive Chairman of the Board | Profile | |
| Michael Prevoznik | Senior Vice President General Counsel | Profile | |
| Catherine Doherty | Senior Vice President, Group Executive - Clinical Franchise Solutions and Marketing | Profile | |
| Gabrielle Wolfson | Senior Vice President and Chief Information and Digital Officer | Profile | |
| Carrie Manner | Senior Vice President - Advanced Diagnostics | Profile | |
| Michael Deppe | Vice President Corporate Controller and Chief Accounting Officer and Principal Accounting Officer | Profile | |
| Mark Guinan | Chief Financial Officer, Executive Vice President | Profile | |
| James Davis | Executive Vice President, General Diagnostics | Profile | |
| Sam Samad | Executive CFO | Profile | |
| Gail Wilensky | Independent Director | Profile | |
| Wright Lassiter | Independent Director | Profile | |
| Gary Pfeiffer | Independent Director | Profile | |
| Vicky Gregg | Independent Director | Profile | |
| Helen Torley | Independent Director | Profile | |
| Shawn Bevec | Executive Director Investor Relations | Profile | |
| Timothy Main | Independent Director | Profile | |
| Denise Morrison | Independent Director | Profile | |
| Timothy Ring | Lead Independent Director | Profile | |
| Patrick Plewman | Senior Services | Profile | |
| Garry Clark | Senior Officer | Profile | |
| Kristin Esq | Senior Officer | Profile | |
| Murali Balakumar | Senior Officer | Profile | |
| Cecilia McKenney | Senior Officer | Profile | |
| Tracey Doi | Independent Director | Profile | |
| Karthik Kuppusamy | Senior Solutions | Profile | |
| Manuel Mendez | Senior Vice President Chief Commercial Officer | Profile | |
| Dermot Shorten | MA Strategy | Profile | |
| Gary Samuels | Senior Officer | Profile | |
| Michael JD | Senior Counsel | Profile |
About Quest Diagnostics Management Performance
The success or failure of an entity such as Quest Diagnostics often depends on how effective the management is. Quest Diagnostics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Quest management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Quest management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey. Quest Diagnostics operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 50000 people.
Please note, the imprecision that can be found in Quest Diagnostics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Quest Diagnostics Incorporated. Check Quest Diagnostics' Beneish M Score to see the likelihood of Quest Diagnostics' management manipulating its earnings.
Quest Diagnostics Workforce Analysis
Traditionally, organizations such as Quest Diagnostics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Quest Diagnostics within its industry.Quest Diagnostics Manpower Efficiency
Return on Quest Diagnostics Manpower
| Revenue Per Employee | 179.5K | |
| Revenue Per Executive | 329.1M | |
| Net Income Per Employee | 16.7K | |
| Net Income Per Executive | 30.7M | |
| Working Capital Per Employee | 4.1K | |
| Working Capital Per Executive | 7.4M |
Additional Tools for Quest Stock Analysis
When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.